Bora Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,832	5,077	5,829	3,053	3,281	910.75
Short-Term Investments	38.54	38.37	67.86	342.63	247.62	-
Trading Asset Securities	19.02	20.28	20.28	-	-	-
Cash & Short-Term Investments	4,890	5,136	5,917	3,396	3,529	910.75
Cash Growth	-5.70%	-13.21%	74.25%	-3.77%	287.48%	35.94%
Accounts Receivable	9,511	9,260	10,482	4,028	6,120	824.77
Other Receivables	449.67	344.91	766.08	82.61	286.38	33.23
Receivables	9,961	9,604	11,248	4,111	6,407	858.01
Inventory	3,710	3,410	5,502	2,157	1,991	928.64
Prepaid Expenses	783.58	675.46	591	801.43	242.47	63.07
Other Current Assets	467.96	511.69	118.63	138.63	71.58	31.87
Total Current Assets	19,812	19,338	23,377	10,604	12,241	2,792
Property, Plant & Equipment	11,345	11,183	12,510	7,494	7,300	4,067
Long-Term Investments	5,953	5,929	236.33	21.26	62.03	-
Goodwill	-	2,664	3,618	3,010	983.59	-
Other Intangible Assets	6,206	3,580	3,920	2,665	1,164	171.05
Long-Term Deferred Tax Assets	1,114	1,170	1,190	1,045	829.64	243.78
Other Long-Term Assets	901.45	849.81	657.62	294.85	181.01	98.65
Total Assets	45,332	44,714	45,510	25,134	22,761	7,372
Accounts Payable	938.4	925.1	792.34	380.45	454.74	235.81
Accrued Expenses	-	111.46	132.63	30.86	29.33	321.24
Short-Term Debt	3,410	3,950	2,598	767.51	2,161	645.48
Current Portion of Long-Term Debt	1,047	1,691	1,189	630.5	725.63	222.09
Current Portion of Leases	106.77	80.62	116.6	106.04	75.31	17.54
Current Income Taxes Payable	432.32	321.05	484.33	987.43	238.65	50.58
Current Unearned Revenue	306.71	262.52	245.6	224.6	85.69	20.47
Other Current Liabilities	8,096	5,979	8,250	5,102	6,725	327.91
Total Current Liabilities	14,338	13,321	13,808	8,229	10,496	1,841
Long-Term Debt	12,319	11,796	14,324	2,724	4,037	1,028
Long-Term Leases	663.56	708.9	745.96	763.33	596.88	305.97
Long-Term Unearned Revenue	21.73	88.87	-	-	4.18	-
Pension & Post-Retirement Benefits	-	99.39	129.04	115.36	136.41	136.28
Long-Term Deferred Tax Liabilities	1,035	988.55	1,256	783.9	742.85	609.77
Other Long-Term Liabilities	325.56	239.08	323.59	753.09	1,608	298.57
Total Liabilities	28,703	27,242	30,586	13,368	17,621	4,220
Common Stock	1,277	1,274	1,031	1,014	753.82	684.12
Additional Paid-In Capital	-	6,056	4,408	3,318	1,236	1,026
Retained Earnings	7,099	8,346	7,020	4,729	2,549	1,466
Treasury Stock	-133.67	-134.29	-43.18	-50.97	-53.09	-
Comprehensive Income & Other	6,327	-159.75	362.83	74.66	42.2	-23.26
Total Common Equity	14,569	15,381	12,779	9,085	4,528	3,153
Minority Interest	2,060	2,091	2,144	2,681	612.13	-
Shareholders' Equity	16,629	17,472	14,923	11,766	5,140	3,153
Total Liabilities & Equity	45,332	44,714	45,510	25,134	22,761	7,372
Total Debt	17,547	18,227	18,973	4,991	7,596	2,219
Net Cash (Debt)	-12,657	-13,091	-13,056	-1,595	-4,067	-1,308
Net Cash Per Share	-67.35	-69.41	-92.49	-12.84	-34.34	-11.20
Filing Date Shares Outstanding	123.04	126.99	123.39	121.33	117.01	117.32
Total Common Shares Outstanding	123.04	126.99	123.39	121.33	117.01	117.32
Working Capital	5,475	6,017	9,569	2,375	1,745	951.22
Book Value Per Share	118.41	121.12	103.57	74.88	38.70	26.87
Tangible Book Value	8,363	9,137	5,241	3,410	2,381	2,981
Tangible Book Value Per Share	67.97	71.95	42.47	28.10	20.35	25.41
Land	-	3,758	3,824	3,424	3,397	1,984
Buildings	-	7,289	7,963	1,945	1,905	1,393
Machinery	-	3,870	6,113	2,814	2,390	859.79
Construction In Progress	-	809.38	527.38	115.84	76.72	11.73
Leasehold Improvements	-	-	-	-	205.29	-